# Intuitive Surgical Inc. (ISRG) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $366.70, market value $131.4 billion.

## Valuation
- **P/E (trailing): 42.0×** (5-yr avg 74.0×, 3-yr avg 73.4×). Intuitive Surgical Inc. trades at 42.0× trailing earnings, well below its own five-year average of 74.0×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 30.4×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 1.34**. A PEG of 1.34 is in the range usually read as fairly priced for its growth.
- **Price / sales: 11.9×**. Each dollar of revenue is priced at 11.9×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 7.1×**. The shares trade at 7.1× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: 2.5%** (5-yr avg 1.0%). Free cash flow equals 2.5% of the market value, above its five-year average of 1.0%, so the shares are cheaper on cash than they have usually been.
- **Earnings yield: 2.4%**. The inverse of the P/E: 2.4% of the price is earned each year.

## Profitability
- **Gross margin: 66.7%**. Intuitive Surgical Inc. keeps 66.7% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 31.3%**. 31.3% of revenue is left after running the business, an exceptional level.
- **Net margin: 28.4%**. 28.4% of each dollar of sales reaches the bottom line.
- **Return on equity: 16.0%**. 16.0% on shareholders' equity is solid.
- **Return on assets: 15.3%**. Each dollar of assets produces 15.3% of profit.

## Growth
- **Revenue growth (1 yr): 20.5%** (3-yr 17.4%/yr, 5-yr 18.2%/yr). Revenue grew 20.5% over the last year, against 18.2% a year compounded over five years.
- **EPS growth (1 yr): 22.6%** (3-yr 29.2%/yr, 5-yr 21.8%/yr). Earnings per share rose 22.6%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): 37.5%/yr**. Free cash flow has compounded at 37.5% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Current ratio: 4.87** (quick 4.87). Current assets cover the next year's liabilities 4.87 times.
- **Altman Z-score: 33.96**. A Z-score of 33.96 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Intuitive Surgical Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (30 analysts). 30 analysts cover Intuitive Surgical Inc.; the consensus is buy, with an average price target of $478.01 (+30% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -19.3%** (YTD -35.3%, 3-mo -13.1%). The shares are down 19.3% over twelve months including dividends.
- **From 52-week high: -39.3%** (11.6% above the low). Trading 39% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 43**. An RSI of 43 is neutral.
- **Beta (1 yr): 0.94** (volatility 37%). Beta of 0.94 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ISRG · Page: https://foliofundamentals.com/stocks/isrg

Not investment advice.